Marijuana has a lower potential for abuse than other drugs that are subjected to the same restrictions, with scientific support for its use as a medical treatment, researchers from the US Food and Drug Administration say in documents supporting its reclassification as a Schedule III substance.
Marijuana is currently classified as Schedule I, reserved for the most dangerous controlled substances, including heroin and LSD. In 2022, President Joe Biden asked US Health and Human Services Secretary Xavier Becerra and the attorney general to begin the administrative process of reviewing how marijuana is scheduled under federal law. HHS Assistant Secretary for Health Adm. Rachel Levine wrote a letter to the Drug Enforcement Administration in August in which she supported the reclassification to Schedule III, a list that includes “drugs with a moderate to low potential for physical and psychological dependence” such as ketamine, testosterone and Tylenol with codeine.
…
Rescheduling marijuana could open up more avenues for research, allow cannabis businesses to bank more freely and openly, and have firms no longer subject to a 40-year-old tax code that disallows credits and deductions from income generated by sales of Schedule I and II substances.
Wait, Ketamine and lean are schedule three* drugs? I thought those were pretty addictive and pretty damaging?
Edited number
Schedule 3
Whoops, meant to say “aren’t”
Ketamine has medical applications such as being commonly used as an anesthetic in short term procedures and with those who do not respond positively to opioids. Ketamine is classified under low addiction risk as it’s not physically addicting as in its users do not suffer from withdrawal. The problem with ketamine however is that it helps users cope with a plethora of different mental illnesses which in itself is addictive.